お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はウェット型加齢黄斑変性症（AMD）市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはウェット型加齢黄斑変性症（AMD）の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のウェット型加齢黄斑変性症（AMD）市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはウェット型加齢黄斑変性症（AMD）のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にウェット型加齢黄斑変性症（AMD）市場を分類しています。本研究に含まれる主な企業は：Novartis International (Switzerland)、Bayer (Germany)、Acucela (US)、Neurotech Pharmaceuticals (US)、Ophthotech (US)、GlaxoSmithKline (US)、Alimera Sciences (US)、StemCell (Canada)、F. Hoffmann-La Roche (Switzerland)、Regeneron Pharmaceutical (US)、Allergan (Ireland)、Adverum Biotechnologies (US)、Gilead Sciences (US)

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Wet Age-Related Macular Degeneration (Wet AMD)
    Dry Age-Related Macular Degeneration (Dry AMD)

用途別の市場セグメント：
    Above 75 Years
    Above 60 Years
    Above 40 Years

本レポートの詳細内容
世界のウェット型加齢黄斑変性症（AMD）市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、ウェット型加齢黄斑変性症（AMD）タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のウェット型加齢黄斑変性症（AMD）収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のウェット型加齢黄斑変性症（AMD）市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、ウェット型加齢黄斑変性症（AMD）市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

ウェット型加齢黄斑変性症（AMD）のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：ウェット型加齢黄斑変性症（AMD）のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：ウェット型加齢黄斑変性症（AMD）の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章ウェット型加齢黄斑変性症（AMD）企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：ウェット型加齢黄斑変性症（AMD）の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：ウェット型加齢黄斑変性症（AMD）の主要企業の概要を提供し、製品の説明と仕様、ウェット型加齢黄斑変性症（AMD）の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.
Market Analysis and Insights: Global Wet Age Related Macular Degeneration (AMD) Market
The global Wet Age Related Macular Degeneration (AMD) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.
Report Covers:
This report presents an overview of global market for Wet Age Related Macular Degeneration (AMD) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Wet Age Related Macular Degeneration (AMD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Wet Age Related Macular Degeneration (AMD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Wet Age Related Macular Degeneration (AMD) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Wet Age Related Macular Degeneration (AMD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Age, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Wet Age Related Macular Degeneration (AMD) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis International (Switzerland), Bayer (Germany), Acucela (US), Neurotech Pharmaceuticals (US), Ophthotech (US), GlaxoSmithKline (US), Alimera Sciences (US), StemCell (Canada) and F. Hoffmann-La Roche (Switzerland), etc.
Market Segmentation
By Company
    Novartis International (Switzerland)
    Bayer (Germany)
    Acucela (US)
    Neurotech Pharmaceuticals (US)
    Ophthotech (US)
    GlaxoSmithKline (US)
    Alimera Sciences (US)
    StemCell (Canada)
    F. Hoffmann-La Roche (Switzerland)
    Regeneron Pharmaceutical (US)
    Allergan (Ireland)
    Adverum Biotechnologies (US)
    Gilead Sciences (US)

Segment by Type
    Wet Age-Related Macular Degeneration (Wet AMD)
    Dry Age-Related Macular Degeneration (Dry AMD)

Segment by Age
    Above 75 Years
    Above 60 Years
    Above 40 Years

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Wet Age Related Macular Degeneration (AMD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wet Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Age and by country, revenue for each segment.
Chapter 7: Europe by Type, by Age and by country, revenue for each segment.
Chapter 8: China by Type, and by Age, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Age and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Age and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Wet Age Related Macular Degeneration (AMD) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
    Table 3. Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
    Table 4. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Age (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Wet Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2019-2024)
    Table 8. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2025-2030)
    Table 10. Wet Age Related Macular Degeneration (AMD) Market Trends
    Table 11. Wet Age Related Macular Degeneration (AMD) Market Drivers
    Table 12. Wet Age Related Macular Degeneration (AMD) Market Challenges
    Table 13. Wet Age Related Macular Degeneration (AMD) Market Restraints
    Table 14. Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players (2019-2024)
    Table 16. Global Top Wet Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2023)
    Table 17. Global Wet Age Related Macular Degeneration (AMD) Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Wet Age Related Macular Degeneration (AMD), Headquarters and Area Served
    Table 20. Global Key Players of Wet Age Related Macular Degeneration (AMD), Product and Application
    Table 21. Global Key Players of Wet Age Related Macular Degeneration (AMD), Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2019-2024)
    Table 25. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2025-2030)
    Table 27. Global Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 28. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Age (2019-2024)
    Table 29. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2025-2030) & (US$ Million)
    Table 30. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Age (2025-2030)
    Table 31. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 34. North America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2025-2030) & (US$ Million)
    Table 35. North America Wet Age Related Macular Degeneration (AMD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 41. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Age (2025-2030) & (US$ Million)
    Table 42. Europe Wet Age Related Macular Degeneration (AMD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 48. China Wet Age Related Macular Degeneration (AMD) Market Size by Age (2025-2030) & (US$ Million)
    Table 49. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 52. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Age (2025-2030) & (US$ Million)
    Table 53. Asia Wet Age Related Macular Degeneration (AMD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Wet Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Age (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Novartis International (Switzerland) Company Details
    Table 64. Novartis International (Switzerland) Business Overview
    Table 65. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
    Table 66. Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 67. Novartis International (Switzerland) Recent Developments
    Table 68. Bayer (Germany) Company Details
    Table 69. Bayer (Germany) Business Overview
    Table 70. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product
    Table 71. Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 72. Bayer (Germany) Recent Developments
    Table 73. Acucela (US) Company Details
    Table 74. Acucela (US) Business Overview
    Table 75. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 76. Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 77. Acucela (US) Recent Developments
    Table 78. Neurotech Pharmaceuticals (US) Company Details
    Table 79. Neurotech Pharmaceuticals (US) Business Overview
    Table 80. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 81. Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 82. Neurotech Pharmaceuticals (US) Recent Developments
    Table 83. Ophthotech (US) Company Details
    Table 84. Ophthotech (US) Business Overview
    Table 85. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 86. Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 87. Ophthotech (US) Recent Developments
    Table 88. GlaxoSmithKline (US) Company Details
    Table 89. GlaxoSmithKline (US) Business Overview
    Table 90. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 91. GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 92. GlaxoSmithKline (US) Recent Developments
    Table 93. Alimera Sciences (US) Company Details
    Table 94. Alimera Sciences (US) Business Overview
    Table 95. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 96. Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 97. Alimera Sciences (US) Recent Developments
    Table 98. StemCell (Canada) Company Details
    Table 99. StemCell (Canada) Business Overview
    Table 100. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product
    Table 101. StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 102. StemCell (Canada) Recent Developments
    Table 103. F. Hoffmann-La Roche (Switzerland) Company Details
    Table 104. F. Hoffmann-La Roche (Switzerland) Business Overview
    Table 105. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
    Table 106. F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 107. F. Hoffmann-La Roche (Switzerland) Recent Developments
    Table 108. Regeneron Pharmaceutical (US) Company Details
    Table 109. Regeneron Pharmaceutical (US) Business Overview
    Table 110. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 111. Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 112. Regeneron Pharmaceutical (US) Recent Developments
    Table 113. Allergan (Ireland) Company Details
    Table 114. Allergan (Ireland) Business Overview
    Table 115. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product
    Table 116. Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 117. Allergan (Ireland) Recent Developments
    Table 118. Adverum Biotechnologies (US) Company Details
    Table 119. Adverum Biotechnologies (US) Business Overview
    Table 120. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 121. Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 122. Adverum Biotechnologies (US) Recent Developments
    Table 123. Gilead Sciences (US) Company Details
    Table 124. Gilead Sciences (US) Business Overview
    Table 125. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
    Table 126. Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2019-2024) & (US$ Million)
    Table 127. Gilead Sciences (US) Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Wet Age Related Macular Degeneration (AMD) Market Share by Type: 2023 VS 2030
    Figure 3. Wet Age-Related Macular Degeneration (Wet AMD) Features
    Figure 4. Dry Age-Related Macular Degeneration (Dry AMD) Features
    Figure 5. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Age, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Wet Age Related Macular Degeneration (AMD) Market Share by Age: 2023 VS 2030
    Figure 7. Above 75 Years Case Studies
    Figure 8. Above 60 Years Case Studies
    Figure 9. Above 40 Years Case Studies
    Figure 10. Wet Age Related Macular Degeneration (AMD) Report Years Considered
    Figure 11. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Wet Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region: 2023 VS 2030
    Figure 14. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players in 2023
    Figure 15. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2023
    Figure 17. North America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2019-2030)
    Figure 19. North America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2019-2030)
    Figure 20. North America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
    Figure 21. United States Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2019-2030)
    Figure 25. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Age (2019-2030)
    Figure 26. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
    Figure 27. Germany Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Wet Age Related Macular Degeneration (AMD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Wet Age Related Macular Degeneration (AMD) Market Share by Type (2019-2030)
    Figure 35. China Wet Age Related Macular Degeneration (AMD) Market Share by Age (2019-2030)
    Figure 36. Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Wet Age Related Macular Degeneration (AMD) Market Share by Type (2019-2030)
    Figure 38. Asia Wet Age Related Macular Degeneration (AMD) Market Share by Age (2019-2030)
    Figure 39. Asia Wet Age Related Macular Degeneration (AMD) Market Share by Region (2019-2030)
    Figure 40. Japan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Age (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2019-2030)
    Figure 50. Brazil Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 57. Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 58. Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 59. Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 60. Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 61. GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 62. Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 63. StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 64. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 65. Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 66. Allergan (Ireland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 67. Adverum Biotechnologies (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 68. Gilead Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed